期刊
METABOLITES
卷 13, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/metabo13040569
关键词
metabolomics; ketone bodies; cerebrospinal fluid; Alzheimer's; blood brain barrier
Brain glucose hypometabolism is an early sign of Alzheimer's disease (AD), and interventions like ketogenic diets that offset this deficit show promise as AD therapeutics. On the other hand, high-fat feeding may worsen AD risk. This study found that triglyceride infusions had different effects on the ketones in the brain, especially in individuals with cognitive impairment. The results suggest that increasing plasma ketones may lead to higher brain ketones in high-risk groups and should be further studied.
Brain glucose hypometabolism is an early sign of Alzheimer's disease (AD), and interventions which offset this deficit, such as ketogenic diets, show promise as AD therapeutics. Conversely, high-fat feeding may exacerbate AD risk. We analyzed the metabolomic profile of cerebrospinal fluid (CSF) in a pilot study of older adults who underwent saline and triglyceride (TG) infusions. Older adults (12 cognitively normal (CN), age 65.3 +/- 8.1, and 9 with cognitive impairment (CI), age 70.9 +/- 8.6) underwent a 5 h TG or saline infusion on different days using a random crossover design; CSF was collected at the end of infusion. Aqueous metabolites were measured using a targeted mass spectroscopy (MS) platform focusing on 215 metabolites from over 35 different metabolic pathways. Data were analyzed using MetaboAnalyst 4.0 and SAS. Of the 215 targeted metabolites, 99 were detectable in CSF. Only one metabolite significantly differed by treatment: the ketone body 3-hydroxybutyrate (HBA). Post hoc analyses showed that HBA levels were associated with age and markers of metabolic syndrome and demonstrated different correlation patterns for the two treatments. When analyzed by cognitive diagnosis group, TG-induced increases in HBA were over 3 times higher for those with cognitive impairment (change score CN +9.8 uM +/- 8.3, CI +32.4 +/- 7.4, p = 0.0191). Interestingly, individuals with cognitive impairment had higher HBA levels after TG infusion than those with normal cognition. These results suggest that interventions that increase plasma ketones may lead to higher brain ketones in groups at risk for AD and should be confirmed in larger intervention studies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据